Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Laryngoscope ; 130(12): 2891-2895, 2020 12.
Article in English | MEDLINE | ID: mdl-32031695

ABSTRACT

OBJECTIVES: There are no hearing protection regulations in place for passengers using public transport, such as the London Underground. In light of this, we sought to examine sound pressure levels experienced by regular users of the London Underground. METHODS: Sound pressure levels (A-weighted decibels: dBA) were taken on moving London Underground carriages between Euston and South Wimbledon on the Northern Line, and between Euston and Vauxhall on the Victoria Line, during 2006 and 2018. In addition, carriage sound pressure levels travelling within Zone 1 of the London Underground were tested in 2019. Three experimental and three technical repeats were undertaken using a hand-held calibrated multi-function sound level meter. RESULTS: Passengers are routinely and consistently subjected to sound pressure levels exceeding 80 dBA, with levels sometimes reaching over 100 dBA. CONCLUSION: This study is unique within the literature, with no published studies outlining exposure levels for London Underground passengers. It provides evidence of elevated noise exposure to passengers, consistently along large stretches of the London Underground, over a prolonged study period (2006-2019). KEY WORDS: Sensorineural hearing losssound pressureexposureLondonundergroundtube. LEVEL OF EVIDENCE: N/A Laryngoscope, 2020.


Subject(s)
Hearing Loss, Noise-Induced/epidemiology , Noise, Transportation/adverse effects , Environmental Exposure , Environmental Monitoring , Humans , London/epidemiology
3.
J Surg Case Rep ; 2019(4): rjz092, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30967930

ABSTRACT

Mucoepidermoid variant of thyroid carcinoma is a rare and complex disease. Securing a diagnosis and formulating an evidence-based treatment plan is challenging. A case report of a patient with the dual pathology of a composite mucoepidermoid carcinoma of the thyroid and a follicular variant of papillary thyroid carcinoma with malignant metastasis is presented in this article. We discuss the challenges in diagnosis, prognostic factors and management of this rare presentation by reviewing current literature.

4.
J Surg Case Rep ; 2018(11): rjy321, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30515294

ABSTRACT

Sinonasal inverted papilloma (IP) is a benign tumour with an extremely low incidence in children. We report the case of an 11-year-old Caucasian male presenting with recurrent right-sided epistaxis, nasal obstruction and a mass in the right nasal cavity. An initial diagnosis of a nasopharyngeal angiofibroma was considered; however, on detailed histological examination, the mass was found to be an inverted papilloma. This report aims to increase awareness of IP in the paediatric age group, as well as reinforcing the role of endoscopic surgery in the management of this condition.

5.
Br Med Bull ; 114(1): 75-94, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25790819

ABSTRACT

BACKGROUND: Phenoxy herbicides have been used widely in agriculture, forestry, parks and domestic gardens. Early studies linked them with soft-tissue sarcoma (STS) and non-Hodgkin lymphoma (NHL), but when last reviewed by the International Agency for Research on Cancer in 1986, the evidence for human carcinogenicity was limited. SOURCES OF DATA: We searched Medline and Embase, looking for cohort or case-control studies that provided data on risk of STS and/or NHL in relation to phenoxy herbicides, and checked the reference lists of relevant publications for papers that had been missed. AREAS OF AGREEMENT, AREAS OF CONTROVERSY: The extensive evidence is not entirely consistent, and a hazard of STS or NHL cannot firmly be ruled out. However, if there is a hazard, then absolute risks must be small. GROWING POINTS, AREAS TIMELY FOR DEVELOPING RESEARCH: Extended follow-up of previously assembled cohorts may be the most efficient way of further reducing uncertainties.


Subject(s)
Herbicides/toxicity , Lymphoma, Non-Hodgkin/chemically induced , Sarcoma/chemically induced , Case-Control Studies , Cohort Studies , Humans , Lymphoma, Non-Hodgkin/epidemiology , Occupational Diseases/chemically induced , Occupational Diseases/epidemiology , Occupational Exposure/adverse effects , Risk Assessment/methods , Sarcoma/epidemiology
6.
Occup Environ Med ; 72(6): 435-41, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25694496

ABSTRACT

OBJECTIVES: To provide further information on the possible carcinogenicity of phenoxy herbicides, and in particular their relationship to soft tissue sarcoma (STS), non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL). METHODS: We extended follow-up to December 2012 for 8036 men employed at five factories in the UK which had manufactured phenoxy herbicides, or in a contract spraying business. Mortality was compared with that for England and Wales by the person-years method. Nested case-control analyses compared men with incident or fatal STS (n=15) or NHL/CLL (n=74) and matched controls (up to 10 per case). RESULTS: 4093 men had died, including 2303 since the last follow-up. Mortality from all causes and all cancers was close to expectation, but an excess of deaths from NHL was observed among men who had worked for ≥1 year in jobs with more than background exposure to phenoxy herbicides (19 deaths, SMR 1.85, 95% CI 1.12 to 2.89). Four deaths from STS occurred among men potentially exposed above background (3.3 expected). In the nested case-control analyses, there were no significantly elevated risks or consistent trends across categories of potential exposure for either STS or NHL/CLL. Among men who had worked for ≥1 year in potentially exposed jobs, the highest OR (for STS) was only 1.30 (95% CI 0.30 to 5.62). CONCLUSIONS: Our findings are consistent with the current balance of epidemiological evidence. If phenoxy herbicides pose a hazard of either STS or NHL, then any absolute increase in risk is likely to be small.


Subject(s)
Herbicides/toxicity , Leukemia, Lymphocytic, Chronic, B-Cell/chemically induced , Lymphoma, Non-Hodgkin/chemically induced , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Sarcoma/chemically induced , Soft Tissue Neoplasms/chemically induced , Adult , Case-Control Studies , Female , Follow-Up Studies , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/mortality , Lymphoma, Non-Hodgkin/mortality , Male , Middle Aged , Occupational Diseases/mortality , Phenols/toxicity , Sarcoma/mortality , Soft Tissue Neoplasms/mortality , United Kingdom/epidemiology
7.
Brain Pathol ; 24(4): 396-403, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24946077

ABSTRACT

In Alzheimer's disease, amyloid-ß (Aß) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of Aß in the walls of capillaries and arteries in CAA suggests that Aß is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble Aß from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including Aß. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of Aß. The failure of perivascular clearance of Aß may be a major factor in the accumulation of Aß in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/metabolism , Brain/physiopathology , Cerebral Amyloid Angiopathy/physiopathology , Aging/physiology , Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Alzheimer Disease/therapy , Animals , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Brain/blood supply , Capillaries/physiopathology , Cerebral Amyloid Angiopathy/genetics , Cerebral Amyloid Angiopathy/therapy , Cerebral Arteries/physiopathology , Humans , Lymphocytes/physiology , Neuroimmunomodulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...